Current Cardiovascular Risk Reports

, Volume 7, Issue 5, pp 315–317 | Cite as

Hypertension in Elderly Diabetic Subjects

Invited Commentary
  • 121 Downloads

Abstract

Diabetes and hypertension often coexist and their association consistently favors cardiovascular disease (CVD) and chronic renal disease. Control of blood pressure to a level of 140/90 mm Hg in people with diabetes can prevent or at least delay CVD and chronic kidney disease. In the past, treatment guidelines have stressed tight blood pressure control (±130/80) for people with diabetes. These recommendations have not been constantly supported by recent large randomized control trials, especially in the elderly. Here we review the recent literature regarding the benefits of blood pressure control in elderly patients with diabetes mellitus. We further focus on evidence for specific recommendations in this population subset.

Keywords

Diabetes Hypertension 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Michel E. Safar declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Winer N, Sowers JR. Diabetes and arterial stiffening. Adv Cardiol. 2007;44:245–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, American Heart A, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165:875–82.PubMedCrossRefGoogle Scholar
  4. 4.
    Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995;91:1432–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43:1388–95.PubMedCrossRefGoogle Scholar
  6. 6.
    Urbina EM, Srinivasan SR, Kieltyka RL, Tang R, Bond MG, Chen W, et al. Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study. Atherosclerosis. 2004;176:157–64.PubMedCrossRefGoogle Scholar
  7. 7.
    van Popele NM, Westendorp IC, Bots ML, Reneman RS, Hoeks AP, Hofman A. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia. 2000;43:665–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, et al. Brachial — ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J. 2005;69:815–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, et al. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. J Hypertens. 2010;28:1141–9.PubMedGoogle Scholar
  10. 10.
    Staessen JA, Thijisq L, Fagard R, Celis H, Birkenhager WH, Bulpitt CJ, et al. Effects of immediate vs delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens. 2004;22:847–57.PubMedCrossRefGoogle Scholar
  11. 11.
    Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR, et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2005;95:29–35.PubMedCrossRefGoogle Scholar
  12. 12.
    Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.PubMedCrossRefGoogle Scholar
  13. 13.
    Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ. 2012;344:d7541.CrossRefGoogle Scholar
  14. 14.
    Rastas S, Pirttila T, Viramo P, Verkkoniemi A, Halonen P, Juva K, et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006;54:912–8.PubMedCrossRefGoogle Scholar
  15. 15.
    van Bemmel T, Woittiez K, Blauw GJ, van der Sman-de Beer F, Dekker FW, Westendorp RG, et al. Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-Plus Study. J Am Soc Nephrol. 2006;17:2561–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55:383–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Stolarz K, Staessen JA, Kawecka-Jaszcz K, Brand E, Bianchi G, Kuznetsova T, et al. Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion. Hypertension. 2004;44:156–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–64.PubMedCrossRefGoogle Scholar
  19. 19.
    Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527–39.PubMedCrossRefGoogle Scholar
  20. 20.
    Protogerou AD, Blacher J, Aslangul E, Le Jeunne C, Lekakis J, Mavrikakis M, et al. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis. 2007;193:151–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, et al. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the framingham heart study. Circulation. 2010;122:1379–86.PubMedCrossRefGoogle Scholar
  22. 22.
    Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505–11.PubMedCrossRefGoogle Scholar
  23. 23.
    • Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61:943–947. This reference highlights the main results of the present commentary.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Centre de Diagnostic et de ThérapeutiqueParisFrance

Personalised recommendations